Showing results (201-210 of 432) with videos related to

Sort By:
Pageof 44
Blood|March 8, 2007
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trialClaude Gardin, Pascal Turlure, Thierry Fagot, et al.
Future Oncology (London, England)|March 14, 2020
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemiaPau Montesinos, Benjamin M Beckermann, Olivier Catalani, et al.
Blood|December 3, 2015
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletionVirginie Chesnais, Aline Renneville, Andrea Toma, et al.
The Lancet. Haematology|February 5, 2025
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNetVincent Ribrag, Dominique Bron, Grzegorz Rymkiewicz, et al.
Transfusion|April 22, 2022
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM)Claire Jouzier, Amina Cherait, Pascale Cony-Makhoul, et al.
Blood|July 29, 2010
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)Sylvain Thepot, Raphael Itzykson, Valerie Seegers, et al.
Blood|January 16, 2013
Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Medicine|January 1, 2014
Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 casesArsène Mekinian, Thorsten Braun, Olivier Decaux, et al.
Blood|September 28, 2010
Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasmsFanny Baran-Marszak, Hajer Magdoud, Christophe Desterke, et al.
Leukemia Research|June 24, 2016
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature reviewEric Grignano, Arsene Mekinian, Thorsten Braun, et al.
Pageof 44